Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Current Cardiology Reports

Issue 6/2007

Content (12 Articles)

Late thrombosis with drug-eluting stents: Anatomy of a controversy and lessons learned

  • Editor’s Commentary

Steven E. Nissen

Web Alert

Treating high blood pressure in patients with stable coronary artery disease: How low should we go?

  • Hypertension

β-blockers: No longer an option for uncomplicated hypertension

  • Hypertension

Sripal Bangalore, Gayathri Kamalakkannan, Franz H. Messerli

Primary aldosteronism

  • Hypertension

Richard J. Auchus, Fiemu E. Nwariaku

Renovascular hypertension in 2007: Where are we now?

  • Hypertension

Stephen C. Textor

Arterial stiffness: Is it ready for prime time?

  • Hypertension

Stanley S. Franklin

Aliskiren: The first direct renin inhibitor for hypertension

  • Hypertension

Anton H. van den Meiracker, A. H. Jan Danser

Cardiovascular risk in the metabolic syndrome: Fact or fiction?

  • Lipid Abnormalities and Cardiovascular Prevention

Peter M. Nilsson

HDL metabolism and the role of HDL in the treatment of high-risk patients with cardiovascular disease

  • Lipid Abnormalities and Cardiovascular Prevention

H. Bryan Brewer

New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease

  • Lipid Abnormalities and Cardiovascular Prevention

Philip J. Barter, Rajesh Puranik, Kerry-Anne Rye

Residual risk in statin-treated patients: Future therapeutic options

  • Lipid Abnormalities and Cardiovascular Prevention

Catherine Y. Campbell, Juan J. Rivera, Roger S. Blumenthal

Sep 07
Issue: 5/2007
Jan 08
Issue: 1/2008

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME